We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NGEN Nervgen Pharma Corporation

0.00 (0.00%)
Apr 16 2024 - Closed
Delayed by 15 minutes

Nervgen Pharma Financial Summary

The current NGEN market cap is 122.26M. The company's latest EPS is CAD -0.3525 and P/E is -5.90.

Year End December 30 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 31k0000
Operating Income -1.36M-8.4M-9.93M-11.14M-21.98M
Net Income -1.36M-9.77M-11.19M-12.73M-20.72M
Year End December 30 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 3.1M6.77M6.68M17.9M23.88M
Total Liabilities 583k924k755k1.08M10.41M
Total Equity 2.51M5.84M5.92M16.82M13.46M

Cash Flow

Year End December 30 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -1.04M-8.09M-6.31M-8.27M-17.78M
Investing -127k N/A -3k-44k-21k
Financing 3.59M9.84M7.85M19.61M22.64M
Market Cap 122.26M
Price to Earnings Ratio -5.90
Price to Sales Ratio 0
Price to Cash Ratio 5.45
Price to Book Ratio 9.08
Dividend Yield -

Share Statistics

Shares Outstanding 58.78M
Average Volume (1 week) 47k
Average Volume (1 Month) 153.81k
52 Week Change 18.18%
52 Week High 3.98
52 Week Low 1.50
Spread (Intraday) 0 (0%)

Company Info

Company Name Nervgen Pharma Corporation
Address suite 2600, 595 burrard street
vancouver, british columbia V7X 1L3
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock